This review covers the diverse topic of neuroendocrine neoplasms (NENs), a relatively rare
and heterogeneous tumor type, comprising~ 2% of all malignancies, with a prevalence of< …

Neuroendocrine tumours are a heterogeneous group including, for example, carcinoid,
gastroenteropancreatic neuroendocrine tumours, pituitary tumours, medullary carcinoma of …

In this review, we focus on the use of biochemical markers for the diagnosis of
neuroendocrine tumors and exclusion of conditions that masquerade as neuroendocrine …

Neuroendocrine tumours (NETs) originate in tissues that contain cells derived from the
embryonic neural crest, neuroectoderm and endoderm. Thus, NETs occur at many sites in …

Carcinoid syndrome (CS) is a debilitating disease that affects approximately 20% of patients
with neuroendocrine neoplasms (NEN). Due to the increasing incidence and improved …

Carcinoid syndrome (CS) is a paraneoplastic syndrome caused by the release of serotonin
and other substances from well-differentiated neuroendocrine tumors (NETs). The hallmark …

Purpose At all stages of the disease, serious difficulties are encountered in the imaging
diagnosis of carcinoids. Somatostatin receptor scintigraphy (SRS) holds great promise for …

Pheochromocytomas/paragangliomas are rare tumors; most are sporadic. Biochemical proof
of disease is better with measurement of plasma metanephrines and less cumbersome than …

Objectives To investigate whether screening for malnutrition using the validated malnutrition
universal screening tool (MUST) identifies specific characteristics of patients at risk, in …

Neuroendocrine tumors (NETs) comprise a complex and highly heterogeneous group of
neoplasms that can arise all over the body, originating from neuroendocrine cells. NETs are …